Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 2193014 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | unclassified | |
| long-term survival in multiply transfused patients after hla-identical marrow transplantation is on the order of 60% to 70% | |||||||
| 2193014 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | unclassified | |
| we continue to recommend allogeneic marrow transplantation for patients with severe aplastic anemia who are less than 40 years old and who have hla-identical related donors. | |||||||
| 2193014 | HLA IDENTICAL (HLA-IDENTICAL) | aplastic anemia | NA | NA | NA | unclassified | |
| we continue to recommend allogeneic marrow transplantation for patients with severe aplastic anemia who are less than 40 years old and who have hla-identical related donors. | |||||||
| 2193014 | HLA MISMATCHED (HLA-MISMATCHED) | transplantation | NA | NA | NA | unclassified | |
| hla-mismatched marrow transplantation and use of unrelated marrow donors for severe aplastic anemia remain areas of active research. | |||||||
| 2193014 | HLA MISMATCHED (HLA-MISMATCHED) | aplastic anemia | NA | NA | NA | unclassified | |
| hla-mismatched marrow transplantation and use of unrelated marrow donors for severe aplastic anemia remain areas of active research. | |||||||
| 2193014 | HLA (HLA) | aplastic anemia | NA | NA | NA | unclassified | |
| patients diagnosed with aplastic anemia should have rapid hla typing performed to identify possible marrow donors. | |||||||
| 2193018 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| marrow transplantation from donors other than hla identical siblings. | |||||||
| 2193018 | HLA MATCHED (HLA-MATCHED) | transplantation | NA | NA | NA | unclassified | |
| as marrow transplantation has become the treatment of choice for many hematologic diseases, the lack of hla-matched family donors has become a critical issue. | |||||||
| 2193018 | HLA MATCHED (HLA-MATCHED) | hematologic diseases | NA | NA | NA | unclassified | |
| as marrow transplantation has become the treatment of choice for many hematologic diseases, the lack of hla-matched family donors has become a critical issue. | |||||||
| 2204660 | MHC (MHC) | transplantation | NA | NA | NA | unclassified | |
| during quiescent states without infection or rejection after transplantation, however, a rather restricted expression of class i and class ii donor mhc antigens is present. | |||||||
Copyright 2024